STING1 and lung carcinoma: For example, agonists that activate the cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulation of interferon genes (cGAS-STING) pathway show promise in eliciting a potent anti-cancer immune response in the tumor microenvironment of different cancers including lung cancer (83, 84).